Asston Pharmaceuticals Fair Value
Fair Value Analysis Export
P/B Based Valuation
Asset-Based Valuation
APL Fair Value Analysis — Data Sources & Coverage
Asston Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used. Review Asston Pharmaceuticals P/E valuation to evaluate earnings-based valuation against sector peers.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
APL vs Capital Goods Sector Peers — P/E, P/B & Market Cap
Asston Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Capital Goods sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Rajoo Engineers | RAJOOENG | 20.36 | 3.88 | ₹1,273 |
| Shantai Industries | SHANTAI | -70.98 | 7.5 | ₹58 |
| Equilateral Enterprises | EQUILATERA | 65.88 | 2.43 | ₹26 |
| KPT Industries | KPT | 14.55 | 2.41 | ₹182 |
| Harish Textile Engineers | HARISH | 4.26 | 2.0 | ₹21 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.